Now entering its 13th year of operation, LabConnect provides global central laboratory services including routine and esoteric laboratory testing, kit building, sample management and tracking, biostorage and scientific support services for biopharmaceutical and CRO clients. LabConnect currently has more than 45 locations worldwide and central laboratory capabilities on six continents. LabConnect’s service suite includes: Specialized Testing. With more than 4,000 validated tests across our network, LabConnect can handle everything from general safety testing to the most complex molecular diagnostics and biomarker analyses. Specimen Tracking. LabConnect’s real-time specimen tracking service, SampleGISTICS™, follows the clients’ specimen samples from collection through logistics to receipt at any lab or storage location in the world. Scientific Operations Support. LabConnect provides dedicated contract scientific professionals based upon the specific functional expertise our clients require. These personnel are contracted as needed and have the scientific knowledge to handle intricate clinical protocols and the management of our clients’ internal and external research and development projects. Biostorage Solutions. LabConnect offers a comprehensive suite of biostorage solutions for multiple sample types.
Company Growth (employees)
Seattle, US
Size (employees)
148 (est)
LabConnect was founded in 2002 and is headquartered in Seattle, US

LabConnect Office Locations

LabConnect has offices in Seattle, Johnson City, Bucharest, Minsk and in 7 other locations
Seattle, US (HQ)
605 1st Ave
Show all (11)

LabConnect Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$28.5 m

Latest funding size

$24.5 m

Time since last funding

7 months


LabConnect's latest funding round in June 2017 was reported to be $24.5 m. In total, LabConnect has raised $28.5 m

LabConnect's Web-traffic and Trends

LabConnect Online and Social Media Presence

LabConnect News and Updates

LabConnect pulls in $24.5 mln Series A

Seattle-based LabConnect, provider of laboratory and support services to biopharmaceutical, medical device and contract research organizations, has raised $24.5 million in Series A funding. The investors were ABS Capital Partners, Pablo Capital and BroadOak Capital. In conjunction with the funding, …

LabConnect Company Life and Culture

You may also be interested in